JP2005531290A5 - - Google Patents

Download PDF

Info

Publication number
JP2005531290A5
JP2005531290A5 JP2003570686A JP2003570686A JP2005531290A5 JP 2005531290 A5 JP2005531290 A5 JP 2005531290A5 JP 2003570686 A JP2003570686 A JP 2003570686A JP 2003570686 A JP2003570686 A JP 2003570686A JP 2005531290 A5 JP2005531290 A5 JP 2005531290A5
Authority
JP
Japan
Prior art keywords
nucleic acid
cap
hhh
group
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003570686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005531290A (ja
Filing date
Publication date
Priority claimed from US10/085,117 external-priority patent/US20030232334A1/en
Application filed filed Critical
Publication of JP2005531290A publication Critical patent/JP2005531290A/ja
Publication of JP2005531290A5 publication Critical patent/JP2005531290A5/ja
Withdrawn legal-status Critical Current

Links

JP2003570686A 2002-02-27 2003-02-27 癌のための新規の組成物および方法 Withdrawn JP2005531290A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/085,117 US20030232334A1 (en) 2000-12-22 2002-02-27 Novel compositions and methods for cancer
PCT/US2003/006146 WO2003071933A2 (en) 2002-02-27 2003-02-27 Novel compositions and methods for cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009105737A Division JP2009195241A (ja) 2002-02-27 2009-04-23 癌のための新規の組成物および方法

Publications (2)

Publication Number Publication Date
JP2005531290A JP2005531290A (ja) 2005-10-20
JP2005531290A5 true JP2005531290A5 (enExample) 2006-04-13

Family

ID=27765332

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003570686A Withdrawn JP2005531290A (ja) 2002-02-27 2003-02-27 癌のための新規の組成物および方法
JP2009105737A Withdrawn JP2009195241A (ja) 2002-02-27 2009-04-23 癌のための新規の組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009105737A Withdrawn JP2009195241A (ja) 2002-02-27 2009-04-23 癌のための新規の組成物および方法

Country Status (6)

Country Link
US (1) US20030232334A1 (enExample)
EP (2) EP2031076A1 (enExample)
JP (2) JP2005531290A (enExample)
AU (1) AU2003224641A1 (enExample)
CA (1) CA2477225A1 (enExample)
WO (1) WO2003071933A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060194265A1 (en) * 2001-10-23 2006-08-31 Morris David W Novel therapeutic targets in cancer
AU2003255337A1 (en) * 2002-07-31 2004-02-23 Kylix B.V. Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
US8580814B2 (en) * 2006-04-03 2013-11-12 Sunesis Pharmaceuticals, Inc. Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4- oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
TW200726845A (en) * 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
WO2009061890A1 (en) * 2007-11-08 2009-05-14 St. Jude Children's Research Hospital Methods and compositions for the diagnosis, prognosis and treatment of chronic myeloid leukemia and acute lymphoblastic leukemia
US10890579B2 (en) 2016-10-06 2021-01-12 The Research Foundation For The State University Of New York Methods and kits for detecting a fusion messenger RNA transcript or a polypeptide encoded by the fusion messenger RNA transcript

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) * 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4640835A (en) * 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
US5430136A (en) * 1984-10-16 1995-07-04 Chiron Corporation Oligonucleotides having selectably cleavable and/or abasic sites
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
EP0272253A4 (en) 1986-03-07 1990-02-05 Massachusetts Inst Technology METHOD FOR IMPROVING GLYCOPROTE INSTABILITY.
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5124246A (en) * 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5359100A (en) * 1987-10-15 1994-10-25 Chiron Corporation Bifunctional blocked phosphoramidites useful in making nucleic acid mutimers
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8823869D0 (en) * 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
CA2049028A1 (en) 1989-03-07 1990-09-08 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
WO1991004753A1 (en) 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
US5386023A (en) * 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) * 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) * 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5545806A (en) * 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5644048A (en) * 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5637684A (en) * 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5597909A (en) 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
US5580731A (en) * 1994-08-25 1996-12-03 Chiron Corporation N-4 modified pyrimidine deoxynucleotides and oligonucleotide probes synthesized therewith
US5681702A (en) * 1994-08-30 1997-10-28 Chiron Corporation Reduction of nonspecific hybridization by using novel base-pairing schemes
US5759776A (en) * 1995-06-05 1998-06-02 California Pacific Medical Center Targets for breast cancer diagnosis and treatment
US5776683A (en) * 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6074825A (en) * 1997-07-31 2000-06-13 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
US6153441A (en) * 1998-02-17 2000-11-28 Smithkline Beecham Corporation Methods of screening for agonists and antagonists for human CCR7 receptor and CKβ-9 ligand and interaction thereof
US6008048A (en) * 1998-12-04 1999-12-28 Isis Pharmaceuticals Inc. Antisense inhibition of EGR-1 expression
NL1033850C2 (nl) 2007-05-15 2008-11-18 3Force B V Brandersysteem met voorgemengde branders en vlam-overdrachtsmiddelen.
WO2013037693A2 (de) 2011-09-15 2013-03-21 Convergent Information Technologies Gmbh System und verfahren zur automatisierten erstellung von roboterprogrammen
US9505153B2 (en) 2012-02-13 2016-11-29 Radius Engineering, Inc. Reusable cartridge for injection molding

Similar Documents

Publication Publication Date Title
JP2006507794A5 (enExample)
Bulyk Protein binding microarrays for the characterization of DNA–protein interactions
Hanash et al. Integrating cancer genomics and proteomics in the post‐genome era
CA2488404A1 (en) Genes and polypeptides relating to human colon cancers
JP2005514923A5 (enExample)
JP2007506426A5 (enExample)
NZ548655A (en) Predicting bone relapse of breast cancer using markers
JP2005522999A5 (enExample)
WO2001070174A3 (en) Vegf-modulated genes and methods employing them
JP2010508855A5 (enExample)
JP2005512558A5 (enExample)
Mahon et al. Is persistent adenovirus 12 infection involved in coeliac disease? A search for viral DNA using the polymerase chain reaction.
JP2003508022A5 (enExample)
CA2362527A1 (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Wong et al. Induction of the interleukin-2/15 receptor β-chain by the EWS–WT1 translocation product
JP2008512984A5 (enExample)
JP2004526421A5 (enExample)
Matsushita et al. Merkel cell polyomavirus (MCPyV) strains in Japanese merkel cell carcinomas (MCC) are distinct from Caucasian type MCPyVs: genetic variability and phylogeny of MCPyV genomes obtained from Japanese MCPyV-infected MCCs
Cline et al. The effects of alternative splicing on transmembrane proteins in the mouse genome
JP2005531290A5 (enExample)
JP2005511023A5 (enExample)
JP2005535289A5 (enExample)
JP2005526508A5 (enExample)
Liew Expressed genome molecular signatures of heart failure.
JP2006501465A5 (enExample)